endocrine
Anatomy and Physiology of the Endocrine System
Endocrine Glands: Include pineal, thymus, hypothalamus, pituitary, thyroid, parathyroid, pancreas, ovaries, testes, and placenta.
Hormone Actions: Hormones exert influence on targeted organs.
Negative Feedback: Increased activity leads to decreased hormone release to maintain homeostasis.
Endocrine Glands and Their Functions
Pituitary Gland:
Anterior: Regulates other endocrine glands, secretes growth hormone.
Posterior: Secretes oxytocin and antidiuretic hormone (ADH).
Thyroid Gland:
Produces T3 (triiodothyronine) and T4 (thyroxine) for metabolism.
Calcitonin regulates calcium levels.
Adrenal Glands:
Cortex: Produces mineralocorticoids (aldosterone), glucocorticoids (cortisol), sex hormones.
Medulla: Releases epinephrine and norepinephrine.
Pancreas:
Produces insulin (lowers blood glucose) and glucagon (raises blood glucose).
Ovaries:
Produce estrogen and progesterone.
Testes:
Produce testosterone.
Hormonal Effects on Target Organs
ADH: Increases water reabsorption in kidneys.
Oxytocin: Stimulates milk ejection and uterine contractions.
Insulin/Glucagon: Controls blood sugar levels.
Thyroid Hormones: Regulate metabolic rate and energy.
Parathyroid Hormone (PTH): Increases blood calcium levels.
Mineralocorticoids: Manage electrolyte balance.
Disorders of the Endocrine System
Diabetes Insipidus: Caused by lack of ADH, leading to severe diuresis.
Ketoacidosis: Resulting from extreme insulin deficiency, leading to metabolic acidosis.
Acromegaly/Gigantism: Caused by excess growth hormone, leading to abnormal growth.
Hypothyroidism/Hyperthyroidism: Under or overactivity of thyroid hormones, affecting metabolism.
Cushing's Syndrome/Addison's Disease: Disorders of adrenal hormone production.
Diagnostic Tests for Diabetes
HbA1c Test: Reflects average blood glucose over 8-12 weeks.
Fasting Blood Glucose: >125 mg/dL indicates diabetes.
Oral Glucose Tolerance Test: Assesses body's glucose management (results > 200 mg/dL indicate diabetes).
Management of Diabetes Mellitus
DM Type 1: Requires insulin therapy. Symptoms: polyuria, polydipsia, weight loss.
DM Type 2: Associated with insulin resistance; often linked to obesity.
Complications: Long-term risks include nephropathy, neuropathy, retinopathy, and cardiovascular disease.
Management: Includes diet control, exercise, and medications like insulin and oral hypoglycemics.